Disclaimer: This is an early beta prototype. If you find any error, with data or functionality, please let us know via this page.
Registration date period
Results ordered by trial registration date, descending.
  1. Efficacy and safety of ivermectin against Trichuris trichiura

    Registration date:
    Status:
    Ongoing
    Recruitment status:
    Recruiting
    Source name:
    ISRCTN

    Background and study aims Parasitic worms are organisms that live in the intestine and feed off their living hosts. They are among the most common type of infections worldwide, especially in poor and...

    Conditions:
    • Trichuris infection
    Interventions:
    • Ivermectin
  2. A web-based program to reduce food-related fears and promote healthy dietary habits in toddlers

    Registration date:
    Status:
    Ongoing
    Recruitment status:
    Not recruiting
    Source name:
    ISRCTN

    Background and study aims A child’s first years of life are crucial for cognitive (mental) development and future health. Studies show that a varied diet with a high intake of vegetables is positive...

    Conditions:
    • Dietary habits, food neophobia, cognitive development, child obesity and parental and kindergarten personnel feeding practices
    Interventions:

    Unknown

  3. A Study of Venetoclax in Combination with Azacitidine Versus Azacitidine in previously untreated Subjects with Acute Myeloid Leukemia who are Ineligible for Standard Induction Therapy

    Registration date:
    Status:
    Ongoing
    Recruitment status:
    Unknown
    Source name:
    EU Clinical Trials Register

    To evaluate if venetoclax in combination with azacitidine will improve overall survival (OS) and composite complete remission rate (complete remission + complete remission with incomplete marrow...

    Conditions:
    • Acute Myeloid Leukemia
    Interventions:
    • VENETOCLAX
  4. Recurrence of chronic posttraumatic bone infection: Risk factors analysis

    Registration date:
    Status:
    Ongoing
    Recruitment status:
    Not recruiting
    Source name:
    ISRCTN

    Background and study aims Osteomyelitis is the term for bone infections. It is a difficult to cure infection and despite improvements in treatment, there has still been a steady increase in its...

    Conditions:
    • Chronic post-traumatic osteomyelitis
    Interventions:

    Unknown

  5. A Study of the Efficacy and Safety of Intranasal Esketamine in the Rapid Reduction of Symptoms of Major Depressive Disorder, in Adults at Imminent Risk for Suicide Estudio de la eficacia y la seguridad de la esketamina intranasal en la reducción rápida de los síntomas del trastorno depresivo mayor, en adultos con riesgo inminente de suicidio

    Registration date:
    Status:
    Ongoing
    Recruitment status:
    Unknown
    Source name:
    EU Clinical Trials Register

    The primary objective is to evaluate the efficacy of intranasal esketamine 84 mg compared with intranasal placebo in addition to comprehensive standard of care in reducing the symptoms of MDD,...

    Conditions:
    • Major Depressive Disorder with Imminent Risk of Suicide
    • Trastorno Depresivo Mayor con riesgo inminente de suicidio
    Interventions:
    • Esketamine - Nasal Solution - eq 140mg/mL esketamine base (eq 161.4 mg/mL esketamine HCl)
  6. Stopping perioperative angiotensin II converting enzyme inhibitors and/or angiotensin receptor blockers in major noncardiac surgery

    Registration date:
    Status:
    Ongoing
    Recruitment status:
    Recruiting
    Source name:
    ISRCTN

    Background and study aims: Many patients after major surgery have detectable levels of a natural marker for injury to the heart which is linked to delayed recovery, infections and/or death. This may...

    Conditions:
    • Patients undergoing major surgery requiring general anaesthesia
    Interventions:
    • Any drug listed either as an angiotensin ii converting enzyme inhibitor or angiotensin receptor blocker
  7. A Study of Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Asymptomatic or Mildly Symptomatic, Previously Untreated, Metastatic Castrate-Resistant Prostate Cancer Estudio de Ipatasertibcon Abiraterona mas Prednisona/prenisolona, comparado con Placebo con Abiraterona mas Prednisona/prenisolona en pacientes adultos masculinos con cancer de próstata metastásico resistente a la castración asintomático o levemente sintomático que no se han tratado previamente

    Registration date:
    Status:
    Ongoing
    Recruitment status:
    Unknown
    Source name:
    EU Clinical Trials Register

    • To evaluate the efficacy in the intent to treat (ITT) population • To evaluate the efficacy in patients with PTEN-loss tumors by immunohistochemistry (IHC) -Evaluar la eficacia en la población...

    Conditions:
    • Metastatic Castrate-Resistant Prostate Cancer
    • Cancer de prostata Metastásico resistente a la castración
    Interventions:
    • ipatasertib 100mg
    • ipatasertib 200mg
  8. A Study of Venetoclax Co-Administered with Low Dose Cytarabine Versus Low Dose Cytarabine in Untreated Patients with Acute Myeloid Leukemia Who Are Ineligible for Intensive Chemotherapy

    Registration date:
    Status:
    Ongoing
    Recruitment status:
    Unknown
    Source name:
    EU Clinical Trials Register

    To evaluate if venetoclax when co-administered with low dose cytarabine (LDAC) improves overall survival (OS) versus LDAC and placebo, in treatment naïve subjects with acute myeloid leukemia (AML).

    Conditions:
    • Acute Myeloid Leukemia
    Interventions:
    • VENETOCLAX